BIRC3-CASP8 axis orchestrates the PANoptosis spectrum: taming the inflammatory storm to prevent post-ischemic heart failure
-
By
-
Quancheng Han
-
Huajing Yuan
-
Yitao Xue
-
Yan Li
-
Yiding Yu
-
June 29, 2026
-
Clinical Scorecard: The Role of the BIRC3-CASP8 Pathway in Regulating PANoptosis: Mitigating Inflammation to Avert Post-Ischemic Heart Failure
At a Glance
| Category | Detail |
|---|
| Condition | Heart Failure |
| Key Mechanisms | BIRC3-CASP8 axis regulating PANoptosis and cell death pathways |
| Target Population | Patients with myocardial ischemia/reperfusion injury |
| Care Setting | Cardiology and critical care settings |
Key Highlights
- I/R injury activates PANoptosis, integrating apoptosis, pyroptosis, and necroptosis.
- BIRC3 upregulation inhibits CASP8, promoting inflammatory cell death.
- Silencing BIRC3 redirects cell death towards apoptosis, preserving membrane integrity.
- Modulating cell death pathways may reduce secondary myocardial injury.
- The study provides insights into therapeutic strategies for heart failure.
Guideline-Based Recommendations
Diagnosis
- Assess myocardial ischemia/reperfusion injury through clinical evaluation and imaging.
Management
- Consider targeting the BIRC3-CASP8 axis to modulate cell death pathways.
Monitoring & Follow-up
- Monitor cardiac function post-I/R injury using echocardiography.
Risks
- Increased inflammation and myocardial damage due to lytic cell death.
Patient & Prescribing Data
Patients experiencing myocardial ischemia/reperfusion injury.
Utilization of gene transfer and pharmacological inhibitors to modulate cell death.
Clinical Best Practices
- Implement strategies to minimize inflammation during myocardial I/R injury.
- Utilize echocardiographic assessments for monitoring cardiac function.
Related Resources & Content
